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Abstract
 
Lymphoproliferative diseases are characterized by massive accumulation of CD4
 
2
 
CD8
 
2
 
B220
 
1
 
(double-negative [DN]) T cells in peripheral organs. Although evidence indicates these cells are
 
derived from mature autoreactive 
 
a
 
/
 
b
 
 T cells, the significance of coreceptor downregulation is
not known. In this study, we examined the role CD4 coreceptor plays in the survival of repeat-
 
edly stimulated T cells. CD4
 
1
 
/
 
1
 
 and CD4
 
2
 
/
 
2
 
 T cells from AND T cell receptor (TCR) trans-
genic mice exhibited similar phenotypes after antigenic stimulation, but the CD4
 
2
 
/
 
2
 
 T cells
survived in much larger numbers than the CD4
 
1
 
/
 
1
 
 cells upon primary and secondary major his-
tocompatibility complex (MHC)/peptide stimulation. Enhanced survival of CD4
 
2
 
/
 
2
 
 T cells
was due to decreased apoptosis rather than enhanced proliferation. Similarly, circumvention of
the CD4/MHC interaction by using a surrogate TCR ligand that does not engage CD4 led to
significant enhancement of CD4
 
1
 
/
 
1
 
 cells than when stimulated with MHC/peptide. Finally,
we generated DN B220
 
1
 
 T cells using an in vitro model system and showed they were more
tolerant to chronic stimulation than CD4
 
1
 
/
 
1
 
 cells. Together, these results indicate that corecep-
tor engagement controls expansion of normal T cells. In the absence of coreceptor, T cells sur-
vive chronic stimulation and express B220 as seen in autoimmune lymphoproliferative diseases.
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Introduction
 
Immune system homeostasis is tightly regulated by activa-
 
tion-induced cell death (AICD),
 
1
 
 which serves as a nega-
tive feedback mechanism controlling proliferation of acti-
 
vated T cells (1, 2). In CD4
 
1
 
/
 
1
 
 T cells, AICD results from
coexpression of the death receptor, Fas, and its ligand, FasL
(3–5). Mouse strains carrying a defect in the expression of
either Fas (lpr) or FasL (gld) suffer from a generalized sys-
temic lymphoproliferative disease and autoantibody pro-
duction (6–8). Patients with mutations in Fas or caspase 10
have a similar phenotype highlighting the importance of
this pathway in T cell homeostasis (9–11). The predomi-
nant immunologic abnormality of the lymphoid system in
these diseases is progressive accumulation of a peculiar sub-
set of double-negative (DN) T cells that lack both CD4
and CD8 coreceptors and express the B cell surface mole-
cule B220 (12). Biochemical and genetic evidence suggests
that DN T cells seen in these disorders are derived from
 
mature 
 
a
 
/
 
b
 
 T cells that have downregulated their corecep-
tors (12–14). However, the role of coreceptor downregula-
tion in the development of these cells is not known.
CD4 and CD8 coreceptors are well known for their roles
in the development and activation of helper and cytotoxic
T cells, respectively (15–17). Recent studies suggest that
engagement of coreceptors may also prime T cells for apop-
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Abbreviations used in this paper:
 
 AICD, activation-induced cell death;
CFSE, 5- and 6-carboxyfluorescein diacetate succinimidyl ester; DN,
double-negative; MCC, moth cytochrome c; tg, transgenic. 
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tosis possibly by transducing a negative signal (18, 19). This
signal seems to be mediated by FasL, as CD4 cross-linking
on T cells or CD4-expressing monocytes leads to FasL ex-
pression in a TCR-independent fashion (20–22). Taken to-
gether, these observations have led to the idea that if CD4
engagement plays a specific role in priming activated T cells
for AICD, absence of such signals during TCR stimulation
may render T cells less susceptible to apoptosis. Investigat-
ing this possibility can shed further light on the physiology
of CD4 coreceptor and the role of coreceptor downregula-
tion on the survival of autoreactive T cells.
We therefore investigated the consequences of corecep-
tor engagement on the survival of activated T cells. This
was analyzed using AND TCR transgenic (tg) mice bred
onto either a wild-type CD4
 
1
 
/
 
1
 
 or CD4
 
2
 
/
 
2
 
 background
(23–25) and a set of TCR ligands, MHC/peptide and anti-
CD3, that differentially engage CD4. We found that TCR
stimulation in the absence of coreceptor led to significantly
enhanced survival of activated T cells. CD4
 
2
 
/
 
2
 
 AND T
cells survived in much large numbers regardless of the
TCR ligand used. Enhanced survival of the CD4
 
2
 
/
 
2
 
 cells
was found to be dependent on reduced apoptosis rather
than enhanced proliferation. On the other hand, survival of
activated CD4
 
1
 
/
 
1
 
 T cells was dependent on the TCR
ligand used. When stimulated with MHC/peptide, the nat-
ural ligand for CD4, significant apoptosis occurred,
whereas anti-CD3 led to significant survival of T cells. Fi-
nally, we generated DN T cells from initially CD4
 
1
 
/
 
1
 
 T
cell cultures, using a novel in vitro model system, and
found that DN T cells survived chronic stimulation
whereas the CD4
 
1
 
/
 
1
 
 T cells died out within 4–5 wk of
stimulation. Interestingly, the DN T cells also upregulated
B220, which is phenotypically similar to the CD4
 
2
 
CD8
 
2
 
B220
 
1
 
 T cells seen in lymphoproliferative diseases.
These results indicate that coreceptor engagement limits
expansion of normal T cells by enhancing apoptosis,
whereas lack of coreceptor allows T cell to tolerate chronic
stimulation.
 
Materials and Methods
 
Mice.
 
AND V
 
a
 
11/V
 
b
 
3 
 
a
 
/
 
b
 
 TCR tg mice specific for moth
cytochrome c (MCC) in the context of I-E
 
k
 
 (23) backcrossed to
B10. BR mice (H-2
 
k
 
) for 6–8 generations (24) were a gift of Dr.
S. Swain (Trudeau Institute, Saranac, NY). CD4
 
2
 
/
 
2
 
 AND TCR
tg mice on B10.BR background were produced using a breeding
scheme and mice provided by Dr. K. Bottomly (Yale University,
New Haven, CT) (25). All mice were bred and maintained at the
Cancer Center of the Johns Hopkins School of Medicine.
 
Stimulatory Beads.
 
I-E
 
k
 
/MCC/anti-CD28 beads were pre-
pared using soluble monomeric I-E
 
k
 
 covalently linked to the
MCC 91–103 peptide, a gift of Drs. J. Kappler and P. Marrack
(National Jewish Medical and Research Center, Denver, CO).
Soluble I-E
 
k
 
/MCC was purified from culture supernatant of in-
fected hi five insect cells (Invitrogen) as described previously (26).
I-E
 
k
 
/MCC and anti-CD28 mAb were mixed at 1:1 ratio and
coupled to tosyl-activated 450 Dynabeads (27). Anti-CD3 (145-
2C11)/anti-CD28 (37.51) beads were prepared using the same
protocol.
 
Flow Cytometry.
 
All mAbs were purchased from BD
PharMingen. Cells labeled with fluorescent Abs were analyzed
using FACScan™ flow cytometer (Becton Dickinson) and
CELLQuest™ software (Becton Dickinson).
 
Cell Preparations.
 
T cells were isolated from spleens of
CD4
 
1
 
/
 
1
 
 or CD4
 
2
 
/
 
2
 
 AND 
 
3
 
 B10.BR mice by negative selec-
tion using Dynabeads (Dynal). In brief, splenocytes were incu-
bated with a cocktail of biotin-conjugated rat mAbs specific for
murine CD8, I-E
 
k
 
, CD16/CD32, and B220 surface molecules.
Streptavidin-conjugated beads from Dynal were used to capture
and remove mAb-coated cells using the manufacturer’s instruc-
Figure 1. Phenotype and cytokine production by activated CD42/2
and CD41/1 AND T cells. (A) Phenotype of purified CD41/1 and
CD42/2 AND T cells. AND T cells on CD41/1 or CD42/2 background
were isolated using negative selection as described in Materials and Meth-
ods and then analyzed for Va11 (AND TCR transgene bears Va11 and
Vb3) and CD4 expression. Wt, wild-type; KO, knockout. (B) Activation
marker expression by stimulated and naive AND T cells. CD41/1 and
CD42/2 AND T cells were stimulated with MHC/peptide beads for 6 d
in 24-well plates and then assayed for CD44, CD45RB, and CD62L ex-
pression. Right panel shows CD62L expression on unstimulated CD41/1
and CD42/2 cells. Shaded histograms represent unstained controls. (C)
Cytokines production by activated CD42/2 and CD41/1 T cells. T cells
were collected from day 6 cultures, washed, and stimulated overnight
with various doses of MHC/peptide beads and culture supernatants were
assayed for IFN-g and IL-2 by ELISA. 
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tion. Purity and specificity of isolated T cells were determined by
flow cytometry using mAbs specific for murine V
 
a
 
11, CD8, and
CD4 molecules. Usually 
 
z
 
85–90% of isolated cells were of the
desired phenotype. Stimulation assays were conducted as de-
scribed below.
 
Stimulation Assay.
 
Typically, 10
 
5
 
 tg T cells were stimulated
with an equivalent number of beads in 96-well round-bottomed
microtiter plates or in the case of long-term assays with 2 
 
3
 
 10
 
6
 
beads in a 24-well microtiter plate in the presence of irradiated
feeders. Viability was followed for the indicated time period.
Recombinant IL-2 (20 U/ml) was added on day 0 and thereafter
every 4–5 d in experiments involving CD4
 
2
 
/
 
2
 
 cells to compen-
sate for the inability of the CD4
 
2
 
/
 
2
 
 cells to produce IL-2. Media
was changed and cells were split as required. Fresh beads were
added as indicated in Results and the figure legends. Viable cell
counts were performed on indicated days using standard trypan
blue exclusion.
 
Cytokine Analysis.
 
Cells were removed from stimulation cul-
tures, washed, and incubated with MHC/peptide beads for 24 h.
Supernatants were collected and assayed for indicated cytokines
using captured ELISA according to the manfacturer’s instructions
(Endogen).
 
5- and 6-Carboxyfluorescein Diacetate Succinimidyl Ester Analy-
sis.
 
Purified T cells were labeled with 5- and 6-carboxyfluores-
cein diacetate succinimidyl ester (CFSE) in PBS at a final concen-
tration of 2 
 
m
 
m for 3 min at room temperature. CFSE was
purchased from Molecular Probes. Labeled cells were stimulated
with either MHC/peptide/CD28 or anti-CD3/CD28 beads as
 
described in the figure legends. Cells were analyzed on indicated
days by flow cytometry. In some experiments, cells were also
stained with CyChrome-conjugated anti-CD4 (GK1.5) mAb to
visualize proliferation rate among CD4
 
1
 
/
 
1
 
 and DN T cell subsets.
 
Results
 
Lack of Coreceptor Enhances Survival of Repeatedly Activated
AND T Cells. The tight link between coreceptor down-
regulation and lymphoproliferative disorders suggests that
coreceptor downregulation contributes to the ability of au-
toreactive T cells to avoid peripheral tolerance mecha-
nisms. To examine this idea, we analyzed the consequences
of antigenic stimulation of T cells from CD41/1 and
CD42/2 AND tg mice. Splenocytes from CD42/2 AND
tg mice contained significant numbers of Va111
CD42CD82 T cells as described previously (25). Using
negative selection, we isolated Va111CD42CD82 T cells
from spleens of CD42/2 AND/B10.BR mice or
Va111CD41/1 T cells from spleens of CD41/1 AND/
B10.BR mice, respectively (Fig. 1 A). Isolated T cells were
activated with beads coated with IEk/MCC and anti-CD28
(hereafter referred to as MHC/peptide) in the presence of
exogenous IL-2. CD41/1 and CD42/2 cells activated with
MHC/peptide exhibited similar cell surface markers having
a profile typical of activated T cells, with upregulated
Figure 2. (A) Marked expansion of activated CD42/2 T cells. 105 CD41/1 or
CD42/2 T cells cultured in triplicate with irradiated syngeneic splenocytes in 24-
well plates were stimulated with either MHC/peptide (left) or anti-CD3 (right)
beads in the presence of IL-2. Cultures were restimulated on day 7 to maintain
continuous activation. Media was changed and cells were split as required. Cell
viability was analyzed daily and cell counts were performed on indicated days. Re-
sults represent the mean of three determinants 6 SEM. ko, knockout; Wt, wild-
type. (B) CD41/1 and CD42/2 AND cells proliferate at comparable rates. CFSE-
labeled cells were stimulated with: 2 3 105 (a and e); 1 3 105 (b and f); 0.5 3 105
(c and g); or 0.25 3 105 (d and h) of MHC/peptide beads in the presence of IL-2.
On day 3, CFSE profiles of activated cells were determined using flow cytometry.
WT, wild-type.1116 CD4 Regulates Expansion of a/b T Cells
CD44, intermediate level of CD45RB, and downregulated
CD62L (Fig. 1 B). These cells were clearly activated as in-
dicated by low levels of CD62L expression, which were
high on naive T cells (Fig. 1 B). In addition, both CD41/1
and CD42/2 cells produced large amounts of IFN-g; how-
ever, only CD41/1 cells produced IL-2 (Fig. 1 C). Al-
though CD42/2 T cells did not produce IL-2 at any dose
tested, they did remain responsive to IL-2 and proliferated
at a comparable level to that of CD41/1 cells in the pres-
ence of exogenous IL-2, as described previously (25). Thus,
CD42/2 cells were activated as indicated by cellular activa-
tion profiles, IFN-g production, and response to exoge-
nous IL-2.
We examined the impact of CD4 engagement by
MHC/peptide ligand on the survival and expansion of acti-
vated T cells. Viability of CD41/1 and CD42/2 AND T
cells stimulated with MHC/peptide beads in the presence
of exogenous IL-2 was analyzed during primary and sec-
ondary stimulation. The number of viable CD42/2 T cells
substantially increased upon stimulation and remained high
upon restimulation whereas the number of viable CD41/1
T cells showed a more limited increase followed by a de-
cline after restimulation (Fig. 2 A). There was z10-fold in-
crease in the viability of CD42/2 cells relative to z3-fold
increase in CD41/1 cells after 6 d of stimulation. Cell num-
bers increased from 105 to 106 for CD42/2 cells but only
from 1 3 105 to a maximum of 3 3 105 for CD41/1 cells.
To further analyze the preferential accumulation of
CD42/2 cells, we compared proliferation rates of MHC/
peptide-stimulated CD41/1 and CD42/2 cells using a
CFSE-based proliferation assay. Both CD41/1 and CD42/2
cells proliferated at comparable rates to all the MHC/pep-
tide doses tested (Fig. 2 B). Thus, although CD42/2 cells
were more tolerant to repeated stimulation than their
CD41/1 counterparts, this was not due to differences in the
rate of proliferation.
In contrast to the limited expansion of CD41/1 T cells
stimulated with MHC/peptide, substantial expansion of
Figure 3. Normal proliferation but reduced apoptosis of CD41/1 T cells stimulated in the absence of CD4 engagement. (A) MHC/peptide and anti-
CD3 beads induced similar proliferation but different apoptotic rates. Purified CD41/1 AND T cells were labeled with CFSE and stimulated with: (a)
2 3 105; (b) 1 3 105; (c) 0.5 3 105; or (d) 0.25 3 105 of either MHC/peptide or anti-CD3 beads. Cells were collected on day 3 and CFSE fluores-
cence of cells stimulated with MHC/peptide (thick line) or anti-CD3 (thin line) was analyzed (left panel). CD41/1 T cells were stimulated with various
doses of MHC/peptide or anti-CD3 beads as described above for 6 d and then percentages of apoptotic cells in each culture was determined using an-
nexin V-FITC (right panel). (B) Kinetic analysis of proliferation rates of CD41/1 cells in response to MHC/peptide or anti-CD3 stimulation. 105 AND
T cells were labeled with CFSE and stimulated with an equal number of either MHC/peptide (top) or anti-CD3 (bottom) beads. Cells were collected
and assayed for CFSE fluorescence on indicated days. (C) Soluble Fas:Fc significantly inhibited apoptosis. CD41/1 cells were stimulated with an equiv-
alent number of either MHC/peptide or anti-CD3 beads in the presence or absence of 5 mg/ml recombinant human Fas:Fc and 1.25 mg/ml enhancer
protein (Alexis). 6 d later, apoptosis was analyzed using annexin V assay.1117 Hamad et al.
CD41/1 T cells occurred when stimulated with anti-CD3/
anti-CD28 beads (hereafter referred to as anti-CD3; Fig. 2
A). As this treatment leads exclusively to TCR engagement
and circumvents the CD4/MHC interaction, it also impli-
cates CD4 in regulating survival of activated T cells.
Excluding CD4 during TCR Stimulation Reduces AICD of
CD41/1 T Cells. Increased expansion of CD41/1 T cells
stimulated with anti-CD3 versus MHC/peptide (Fig. 2 A)
could be due to either reduced apoptosis or enhanced pro-
liferation. To differentiate between these two possibilities,
we compared proliferation and apoptosis of CD41/1 cells
stimulated with various doses of MHC/peptide or anti-
CD3. CD41/1 T cells stimulated with varying doses of ei-
ther anti-CD3 or MHC/peptide beads proliferated at com-
parable rates (Fig. 3 A). Similar results were obtained in a
kinetics study tracking proliferation rates of activated cells
over a 7-d period (Fig. 3 B). However, a significant differ-
ence between stimulation with MHC/peptide and anti-
CD3 was seen when apoptosis was analyzed. Stimulation
with anti-CD3 induced two- to threefold less apoptosis
than stimulation with MHC/peptide (Fig. 3 A). Apoptosis
of the activated cells was sensitive to the addition of soluble
Fas:Fc (Fig. 3 C), indicating this was Fas-dependent apop-
tosis. Thus, exclusion of CD4/MHC interaction using a
surrogate TCR ligand, anti-CD3, that does not engage
CD4, led to significant survival of activated T cells due to
limited apoptosis. On the other hand, stimulation of the
CD41/1 cells with MHC/peptide complex, the natural
ligand for CD4, led to similar proliferation rates but a more
limited T cell expansion due to increased apoptosis.
As T cell expansion is regulated mainly by Fas-mediated
death (3, 4, 5; Fig. 3 C), we determined whether expres-
sion of Fas and FasL on AND T cells was affected by the
absence of CD4-dependent signals. Activated CD41/1 T
cells expressed Fas and significant amounts of FasL (Fig. 4).
On the other hand, CD42/2 T cells showed significant Fas
expression but only minimal amounts of FasL expression.
Suboptimal Apoptosis of Activated CD41/1 T Cells Leads to
Appearance and Accumulation of DN T Cells. The accumu-
lation of DN T cells is seen most prominently in autoim-
mune diseases characterized by defects in Fas-mediated
AICD (28) but noticeably absent in other autoimmune dis-
eases. This suggests a link between impaired AICD and de-
velopment of DN T cells. The differential ability of MHC/
peptide and anti-CD3 to induce apoptosis allowed us the
opportunity to study the impact of reduced apoptosis of ac-
tivated CD41/1 T cells on the generation of DN T cells.
We stimulated highly purified CD41/1 T cells for 6 d with
either MHC/peptide or anti-CD3 beads and determined
the percentages of CD4-negative and apoptotic T cells in
Figure 4. CD42/2 T cells did not upregulate FasL. T cells were acti-
vated with MHC/peptide beads as described in the legend to Fig. 1 B for
6 d and then analyzed for (A) Fas and (B) FasL expression. Fas expression
was detected using biotinylated anti-Fas Ab followed by streptavidin-PE
(BD PharMingen). FasL expression was detected using hamster anti–
mouse FasL Ab (MFL3) followed by biotin-conjugated anti–hamster IgG
and streptavidin-PE (BD PharMingen). Shaded histograms represent con-
trol cells stained with secondary Ab and streptavidin-PE. Wt, wild-type;
KO, knockout.
Figure 5. Reduced apoptosis of activated CD41/1 T cells leads to gen-
eration of DN T cells. (A) Purified CD41/1 T cells were stimulated with
MHC/peptide (left) or anti-CD3 (right) beads for 6 d and then stained
and analyzed by flow cytometry. We gated on TCR1 cells and deter-
mined the percentage of CD41 and apoptotic (annexin V1) cells in each
culture. Cells in the left lower quadrant were DN T cells, as they lack
both CD4 and CD8 (data not shown) coreceptors. (B) DN T cells are
specific for I-Ek-MCC. Cells were collected from MHC/peptide (left) or
anti-CD3 (right) cultures and stained simultaneously with I-Ek-MCC
dimer and anti-TCRb (H597) mAb and analyzed by flow cytometry. All
cells including DN T cells in anti-CD3 culture stained positive with I-Ek-
MCC indicating they were all expressing AND TCR transgene.1118 CD4 Regulates Expansion of a/b T Cells
each culture. The MHC/peptide stimulation resulted in a
significant number (22%) of apoptotic T cells but few (3%)
CD4-negative T cells (Fig. 5 A). Conversely, a significant
number (31%) of CD4-negative T cells and few (5%) apop-
totic cells were detected in the anti-CD3–stimulated cul-
ture. Thus, it appears that reducing apoptosis of activated T
cells by excluding direct CD4 engagement leads to accu-
mulation of CD4-negative T cells.
The CD4-negative cells were further analyzed for TCR
antigenic specificity. All CD4-negative T cells expressed
Va11 and Vb3 and could be detected with dimeric MHC/
peptide (29), confirming that anti-CD3 stimulation did not
lead to expansion of nonspecific T cells (Figs. 5 B and 6 A).
In addition, these cells did not express CD8 coreceptor,
confirming they were CD42CD82 (DN) T cells (data not
shown). The CD41/1 cells are the probable precursors for
the DN T cells that accumulated in the chronically stimu-
lated cultures. Were it that these cells originated from the
initial low frequency DN T cells in the original population,
we would have expected to see them in culture stimulated
with either anti-CD3 or MHC/peptide (MHC/peptide–
stimulated CD42/2 cells from CD4 knockout mice; Fig. 2).
Although we cannot completely rule out that accumulation
of DN cells was due to selection of preexisting CD42/2
cells, the fact that DN cells were primarily seen in the anti-
CD3–stimulated cultures indicates that they probably arise
specifically under conditions that caused suboptimal CD4
recruitment and limited apoptosis. However, both scenar-
ios are consistent with the basic hypothesis that the lack of
coreceptor allows accumulation of activated T cells.
Chronic stimulation with anti-CD3 therefore provided a
novel and simple technique to generate DN T cells from
CD41/1 cells and study their survival. Highly purified
CD41/1 T cells isolated from spleens of AND tg mice
(Materials and Methods) were stimulated with anti-CD3
beads to generate DN T cells. Beads were added on day 0,
7, 12, 19, and 26 so that the effect of chronic stimulation
on the survival of CD41/1 T cells and DN T cells could be
studied. The appearance and fate of DN T cells was moni-
tored by analysis of CD4, CD8, and Va11 expression
among surviving cells. Va111CD42CD82 T cells began to
appear on day 2 and gradually expanded at the expense of
the Va111CD41 T cells (Fig. 6 A). After 5 wk of stimula-
tion, all surviving cells were Va111CD42CD82 T cells.
The coreceptor reexpression was not seen in cells rested for
up to 2 wk. The finding that DN T cells tolerated chronic
stimulation is consistent with the ability of CD42/2 knock-
out T cells to survive repeated stimulation. Thus, the data
in all the above experiments indicate that T cells stimulated
through the TCR without involvement of the coreceptor
are more tolerant to repeated stimulation than when the
CD4 coreceptor is engaged.
DN T cells from lpr or gld mice are usually refractory to
most TCR stimuli (30–32). Only a small fraction of these
cells can proliferate and secrete IL-2 if both TCR and
CD28 are engaged (33–35). However, isolating and study-
ing the functional characteristics of these cells has been
hampered by their low frequency and technical difficulties.
Using the CFSE assay, we analyzed the proliferative poten-
tials of DN T cells generated in vitro to determine if they
were functionally competent. CFSE-labeled CD41/1 T
cells were stimulated with anti-CD3 to generate and visual-
ize proliferation of both CD41/1 and CD42/2 cells over a
period of 7 d. Emerging DN T cells displayed similar in-
tensity of fluorescence as the CD41/1 T cells, as both sub-
sets lost fluorescence at a similar rate (Fig. 6 B). Pure DN T
cells were able to grow for up to 10 wk before they became
hyporesponsive and died (data not shown). Thus, DN T
cells generated in vitro are capable of proliferating in re-
sponse to stimulation for a considerable period of time.
Figure 6. DN but not CD41/1 T cells tolerate chronic
stimulation. (A) Kinetic analysis of DN cells accumulation.
CD41/1 T cells isolated by negative selection from spleens
of AND tg mice were continuously stimulated with anti-
CD3 beads. CD4 and Va11 expression on T cells was de-
termined at various time points. Va11 expression was used
to verify specificity of AND T cells, which express Va11
and Vb3. The CD42/2 cells in the lower left quadrant
were not antigen specific and eventually disappeared
around day 7. (B) DN T cells proliferated at a similar rate as
CD41/1 T cells. CD41/1 T cells were purified and labeled
with CFSE and then stimulated with anti-CD3 beads. On
indicated days, T cells were removed and stained with anti-
CD4. The level of CFSE among CD41/1 and DN T cells
was visualized by flow cytometry.
Figure 7. DN T cells generated by chronic stimulation of CD41/1 T
cells express B220. CD41/1 T cells were stimulated with anti-CD3 as in-
dicated above. On the indicated days, samples were collected and analyzed
for CD4 and B220 expression. Eventually all survivors downregulated
CD4 and expressed B220. All cells retained their antigen specificity as de-
termined by Va11 expression (data not shown).1119 Hamad et al.
This feature is critical for studying their function and deter-
mining if it has implications for understanding the function
of DN T cells seen in vivo.
Expression of B220 on DN T Cells. DN T cells seen in
vivo express B220 (36, 37). To determine whether B220 is
expressed on DN T cells generated in vitro, we analyzed
B220 expression on 15-d cultures that contained both
CD41/1 T cells and DN T cells. About 50% of the total
DN T cells in these cultures expressed B220 and their per-
centage gradually increased over time. By the 5th week, all
cells that survived downregulated CD4 and acquired B220
(Fig. 7). All CD42CD82B2201 cells retained their antigen
specificity as determined by homogenous expression of
Va11 among these cells (data not shown). Together, these
results show, at least in this model system, that chronic in
vitro stimulation of T cells that produces suboptimal AICD
leads to accumulation of long-lived T cells bearing the two
hallmarks (lack of coreceptor and expression of B220) of T
cells associated with pathogenic lymphoproliferation.
Discussion
In this study we showed that coreceptor engagement
during TCR activation controls T cell survival. This was
demonstrated using three different approaches. First,
CD42/2 T cells survived in much larger numbers than
CD41/1 cells regardless of the TCR ligand used. Second,
CD41/1 T cells exhibited limited viability when stimulated
with MHC/peptide, the natural ligand for CD4, but en-
hanced viability when stimulated with a surrogate TCR
ligand (anti-CD3) that does not directly engage CD4.
Third, CD41/1 T cells completely disappeared during
chronic stimulation whereas DN T cells survived. The DN
T cells also upregulated B220 and persisted as antigen-spe-
cific CD42CD82B2201 T cells. Together, these data indi-
cate a specific role for the CD4 coreceptor in mediating ap-
optosis of activated T cells and that a lack of coreceptor
allows prolonged survival of activated T cells.
There are at least two mutually nonexclusive mecha-
nisms that may explain the accumulation of activated T
cells in the absence of a CD4/MHC interaction. As CD4-
dependent signals are required for optimal T cell activation,
the absence of CD4 may lead to suboptimal activation.
This explanation does not appear likely for several reasons.
First, in all instances, T cells appeared activated as indicated
by modulation of activation markers and IFN-g produc-
tion. Second, MHC/peptide and anti-CD3 induced com-
parable proliferation but differential apoptosis of CD41/1 T
cells (Fig. 3). Finally, DN and CD41/1 cells present in the
same culture proliferated at a similar rate but the DN T
cells survived chronic stimulation whereas their CD41/1
counterparts died. Therefore, it seems highly unlikely that
enhanced survival of T cells in the absence of direct CD4
signals could be explained by inadequate activation. An al-
ternative possibility is that CD4-specific signals are required
to prime T cells for apoptosis. In the absence of CD4, these
signals are impaired leading to prolonged survival of acti-
vated T cells. Our data and previously published reports
support this model. CD4 seems particularly important for
FasL induction. In our hands, absence of CD4-dependent
signals selectively impaired FasL induction (Fig. 4 B)
whereas previous reports showed that CD4-dependent sig-
nals mediate FasL induction in a TCR-independent fashion
on both T cell and nonlymphoid cells. Together, these data
support a specific role for CD4 in priming T cells for apop-
tosis via regulation of FasL (19, 21, 22, 38).
Variations in the interaction of CD4 coreceptor with
polymorphic class II MHC complex may affect develop-
ment of autoimmune diseases. Our results show that if
CD4 is not properly engaged, T cells could avoid AICD.
By analogy, polymorphism in the CD4 binding site that af-
fects interactions with class II MHC could impair AICD of
autoreactive cells, resulting in autoimmune diseases. Al-
though the CD4 binding site is highly conserved (16, 17),
allelic MHC polymorphism that effects CD4 binding exists
(39). Interestingly, analysis of human MHC class II se-
quences shows that HLA-DQ isotype, which is integral to
several autoimmune diseases, differs from HLA-DR isotype
in key residues in the CD4 binding site. Furthermore, two
DQ alleles with a single residue difference at position 135
that lies within the CD4 binding site are differentially asso-
ciated with celiac disease (40, 41). Thus, variations in the
CD4 binding ability may represent a previously unrecog-
nized element which contributes to class II MHC associa-
tion with autoimmune diseases.
Coreceptor downregulation may have a broader role in
the pathogenesis of autoimmune diseases. Not only Fas-
mediated death, but also TNF-a–mediated AICD has been
reported to be impaired in the absence of CD4 (22). In ad-
dition, coreceptor downregulation may allow T cells to es-
cape regulatory mechanisms that control the ratio of CD4/
CD8 cells, which is very constant in every strain of mouse
and regulated by genes other than those involved in regula-
tion of AICD (42). Therefore, it is conceivable that core-
ceptor downregulation could allow autoreactive CD8 T
cells which disproportionately expand in lymphoprolifera-
tive diseases to escape such mechanism and persist in vivo
as DN cells. Finally, our unpublished data indicate that
downregulation of coreceptor correlates with acquisition of
novel functions directed towards suppression of ongoing
autoreactivity.
In mice with defects in Fas or FasL, most but not all DN
B2201 T cells are refractory to mitogens and TCR-
induced stimulation (34, 35). However, it has been difficult
to isolate the responsive subset of DN T cells and study
their function in vitro. This together with the unknown
specificity of DN cells has hampered progress in under-
standing the biology and role of DN cells in the pathogen-
esis of lymphoproliferative disease despite extensive re-
search. The experimental system described in this study
provides an alternative source of homogenous functional
DN B2201 cells of known antigenic specificity (Fig. 6 B,
and unpublished data). Using this system to understand the
effector function of DN B2201 T cells may lead to new in-
sights into the in vivo function of this important subset of
T cells.1120 CD4 Regulates Expansion of a/b T Cells
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